BIOMAT Database Logo BIOMAT Database Logo

[The effect of secretin on the exocrine and endocrine pancreas. Part II: Plasma insulin and glucagon levels after intravenous secretin or intraduodenal HCl and 1-phenyl-1-hydroxy-n-pentane (author's transl)]. 1979

C Sakamoto, and M Otsuki, and M Maeda, and K Okano, and H Yuu, and S Morita, and N Kobayashi, and K Terashi, and S Baba

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007515 Islets of Langerhans Irregular microscopic structures consisting of cords of endocrine cells that are scattered throughout the PANCREAS among the exocrine acini. Each islet is surrounded by connective tissue fibers and penetrated by a network of capillaries. There are four major cell types. The most abundant beta cells (50-80%) secrete INSULIN. Alpha cells (5-20%) secrete GLUCAGON. PP cells (10-35%) secrete PANCREATIC POLYPEPTIDE. Delta cells (~5%) secrete SOMATOSTATIN. Islands of Langerhans,Islet Cells,Nesidioblasts,Pancreas, Endocrine,Pancreatic Islets,Cell, Islet,Cells, Islet,Endocrine Pancreas,Islet Cell,Islet, Pancreatic,Islets, Pancreatic,Langerhans Islands,Langerhans Islets,Nesidioblast,Pancreatic Islet
D008297 Male Males
D010179 Pancreas A nodular organ in the ABDOMEN that contains a mixture of ENDOCRINE GLANDS and EXOCRINE GLANDS. The small endocrine portion consists of the ISLETS OF LANGERHANS secreting a number of hormones into the blood stream. The large exocrine portion (EXOCRINE PANCREAS) is a compound acinar gland that secretes several digestive enzymes into the pancreatic ductal system that empties into the DUODENUM.
D005934 Glucagon A 29-amino acid pancreatic peptide derived from proglucagon which is also the precursor of intestinal GLUCAGON-LIKE PEPTIDES. Glucagon is secreted by PANCREATIC ALPHA CELLS and plays an important role in regulation of BLOOD GLUCOSE concentration, ketone metabolism, and several other biochemical and physiological processes. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1511) Glucagon (1-29),Glukagon,HG-Factor,Hyperglycemic-Glycogenolytic Factor,Proglucagon (33-61),HG Factor,Hyperglycemic Glycogenolytic Factor
D006728 Hormones Chemical substances having a specific regulatory effect on the activity of a certain organ or organs. The term was originally applied to substances secreted by various ENDOCRINE GLANDS and transported in the bloodstream to the target organs. It is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects. Hormone,Hormone Receptor Agonists,Agonists, Hormone Receptor,Receptor Agonists, Hormone
D000078790 Insulin Secretion Production and release of insulin from PANCREATIC BETA CELLS that primarily occurs in response to elevated BLOOD GLUCOSE levels. Secretion, Insulin
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001592 Benzyl Alcohols Alcohols derived from the aryl radical (C6H5CH2-) and defined by C6H5CHOH. The concept includes derivatives with any substituents on the benzene ring. Phenylcarbinols,Phenylmethanols,Alcohols, Benzyl
D001593 Benzyl Compounds Benzene derivatives that contain a benzyl group with the general formula Phenyl-CH2-R. Compounds, Benzyl

Related Publications

C Sakamoto, and M Otsuki, and M Maeda, and K Okano, and H Yuu, and S Morita, and N Kobayashi, and K Terashi, and S Baba
[Plasma secretin level and exocrine pancreatic secretion in response to intraduodenal infusion of 1-phenyl-1-hydroxy-n-pentane and HCL by using new four lumen tube (author's transl)].
October 1979, Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology,
C Sakamoto, and M Otsuki, and M Maeda, and K Okano, and H Yuu, and S Morita, and N Kobayashi, and K Terashi, and S Baba
Plasma secretin level and exocrine pancreatic secretion in response to intraduodenal infusion of 1-phenyl-1-hydroxy-n-pentane and HCl by using a new four lumen tube.
August 1980, The Tohoku journal of experimental medicine,
C Sakamoto, and M Otsuki, and M Maeda, and K Okano, and H Yuu, and S Morita, and N Kobayashi, and K Terashi, and S Baba
Effect of phenformin on the exocrine function of the pancreas and on insulin secretion after intraduodenal infusion of HCL and intravenous injection of secretin.
December 1973, Diabetes,
C Sakamoto, and M Otsuki, and M Maeda, and K Okano, and H Yuu, and S Morita, and N Kobayashi, and K Terashi, and S Baba
Plasma secretin concentration and pancreatic exocrine secretion after intravenous secretin or intraduodenal HC1 in anaesthetized pigs.
January 1977, Scandinavian journal of gastroenterology,
C Sakamoto, and M Otsuki, and M Maeda, and K Okano, and H Yuu, and S Morita, and N Kobayashi, and K Terashi, and S Baba
[Secretin release caused by oral administration or duodenal infusion of 1-phenyl-1-hydroxy-n-pentane].
December 1976, Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology,
C Sakamoto, and M Otsuki, and M Maeda, and K Okano, and H Yuu, and S Morita, and N Kobayashi, and K Terashi, and S Baba
Dose-response effect of intraduodenal HCl on exocrine pancreatic secretion, portal secretin, and VIP plasma levels in anesthetized rats.
January 1993, Archives internationales de physiologie, de biochimie et de biophysique,
C Sakamoto, and M Otsuki, and M Maeda, and K Okano, and H Yuu, and S Morita, and N Kobayashi, and K Terashi, and S Baba
[The choleretic effect of 1-phenyl-1-hydroxy-n-pentane].
April 1960, Arzneimittel-Forschung,
C Sakamoto, and M Otsuki, and M Maeda, and K Okano, and H Yuu, and S Morita, and N Kobayashi, and K Terashi, and S Baba
[THE CHOLERETIC EFFECT OF 1-PHENYL-1-HYDROXY-N-PENTANE].
March 1964, Arzneimittel-Forschung,
C Sakamoto, and M Otsuki, and M Maeda, and K Okano, and H Yuu, and S Morita, and N Kobayashi, and K Terashi, and S Baba
[Studies on the relationship between endocrine and exocrine pancreatic functions. Part II. Exocrine pancreatic function and insulin and glucagon levels in streptozotocin induced diabetic rats (author's transl)].
August 1977, Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology,
C Sakamoto, and M Otsuki, and M Maeda, and K Okano, and H Yuu, and S Morita, and N Kobayashi, and K Terashi, and S Baba
[On the choleretic activity of some derivatives of 1-phenyl-1-hydroxy-n-pentane and 1-phenyl-1-hydroxy-n-hexane].
November 1961, Bollettino chimico farmaceutico,
Copied contents to your clipboard!